Literature DB >> 3922890

Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins.

F A Klipstein, R F Engert.   

Abstract

The application of dissociation techniques, involving gel filtration in the presence of guanidine, to a semipurified preparation of Campylobacter jejuni heat-labile enterotoxin yielded a material whose functional and immunological properties resemble those of the B subunits of cholera toxin and Escherichia coli heat-labile toxin (LT). The C. jejuni toxin B subunit reacted with GM1 ganglioside in an enzyme-linked immunosorbent assay, but lacked the holotoxin's cytotonic activity in the Chinese hamster ovary tissue culture assay and its ability to cause fluid secretion in rat ileal ligated loops. The C. jejuni toxin B subunit showed lines of partial identity with the B subunits of both cholera toxin and LT in gel immunodiffusion; it appeared to be more closely related immunologically to the LT B subunit than to the cholera toxin B subunit in enzyme-linked immunosorbent assays that used antisera either to LT or to its B subunit. Rats immunized with LT B subunit were significantly protected against challenge with either the semipurified C. jejuni toxin or a viable enterotoxigenic strain of C. jejuni, although twice the immunization dosage was required to achieve protection comparable to that against the homologous toxin or viable bacteria. These observations indicate that the C. jejuni enterotoxin contains a B subunit that bears an immunological relationship with the B subunits of cholera toxin and LT.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922890      PMCID: PMC261211          DOI: 10.1128/iai.48.3.629-633.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Toxins produced by Campylobacter jejuni and Campylobacter coli.

Authors:  W M Johnson; H Lior
Journal:  Lancet       Date:  1984-01-28       Impact factor: 79.321

3.  Production of cholera-like toxin by Campylobacter jejuni/coli.

Authors:  B A McCardell; J M Madden; E C Lee
Journal:  Lancet       Date:  1984-02-25       Impact factor: 79.321

4.  Properties of homogeneous heat-labile enterotoxin from Escherichia coli.

Authors:  J D Clements; R J Yancey; R A Finkelstein
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

Review 5.  Actions of cholera toxin and the prevention and treatment of cholera.

Authors:  J Holmgren
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

6.  Epidemiologic and clinical features of endemic Campylobacter jejuni infection in Bangladesh.

Authors:  R I Glass; B J Stoll; M I Huq; M J Struelens; M Blaser; A K Kibriya
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

7.  Detection of enteric campylobacteriosis in children.

Authors:  V D Bokkenheuser; N J Richardson; J H Bryner; D J Roux; A B Schutte; H J Koornhof; I Freiman; E Hartman
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

8.  Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development.

Authors:  R E Black; M H Merson; I Huq; A R Alim; M Yunus
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

9.  Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin.

Authors:  W S Dallas; S Falkow
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

View more
  13 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

Review 3.  Pathophysiology of Campylobacter enteritis.

Authors:  R I Walker; M B Caldwell; E C Lee; P Guerry; T J Trust; G M Ruiz-Palacios
Journal:  Microbiol Rev       Date:  1986-03

4.  Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin.

Authors:  M John Albert; Shilpa Haridas; David Steer; Gursev S Dhaunsi; A Ian Smith; Ben Adler
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

5.  Anti-GM1 antibodies in patients with Guillain-Barré syndrome.

Authors:  L H van den Berg; J Marrink; A E de Jager; H J de Jong; G W van Imhoff; N Latov; S A Sadiq
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

6.  Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin.

Authors:  M John Albert; Shilpa Haridas; Ben Adler
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

7.  Production of a unique cytotoxin by Campylobacter jejuni.

Authors:  R L Guerrant; C A Wanke; R A Pennie; L J Barrett; A A Lima; A D O'Brien
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

8.  Antibody response to Campylobacter coli in children during intestinal infection and carriage.

Authors:  P M Martin; J Mathiot; J Ipero; A J Georges; M C Georges-Courbot
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

9.  Enterotoxin production and serogroups of Campylobacter jejuni and Campylobacter coli from patients with diarrhea and from healthy laying hens.

Authors:  G B Lindblom; B Kaijser; E Sjögren
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

10.  Enzyme-linked immunosorbent assays for virulence properties of Campylobacter jejuni clinical isolates.

Authors:  F A Klipstein; R F Engert; H B Short
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.